Compliance with continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea among privately paying patients- a cross sectional study

BMC Pulmonary Medicine

Muhammad Islam³  Saba Mansoor⁴  Naveen Alam⁴  Zeeshan Waheed²  Muhammad Irfan⁴  Syed Fayyaz Hussain¹ 

[1] Department of Medicine, Kettering General Hospital, Kettering, UK;Department of Medicine, Armed Forces Hospital Southern Region, Khamis Mushayt, Saudi Arabia;Department of Community Health Sciences, The Aga Khan University Hospital, Karachi, Pakistan;Department of Medicine, The Aga Khan University Hospital, PO Box 3500, Stadium Road, Karachi 74800, Pakistan

关键词: Pakistan;    Side effects;    Compliance;    Continuous positive airway pressure therapy;    Obstructive sleep apnea;   

Others  :  1091144
DOI  :  10.1186/1471-2466-14-188

 received in 2013-07-02, accepted in 2014-11-24,  发布年份 2014

【 摘 要 】

Background

To evaluate the compliance, benefits and side effects associated with continuous positive airway pressure (CPAP) therapy among Pakistani patients treated for obstructive sleep apnea (OSA) in private sector.

Methods

Patients diagnosed to have OSA based on overnight study who were recommended for CPAP therapy, between 1998 and 2003, were evaluated by telephonic survey and review of hospital notes. Compliance, benefits and side effects associated with CPAP therapy were assessed.

Results

Out of 135 patients who were prescribed CPAP therapy, 75 could be contacted. Sixty (80%) started using CPAP within one month of diagnosis and 46 (61%) continued to use it long-term (beyond one year). Compliance with CPAP therapy was associated with higher body mass index, higher Epworth sleepiness scale score, history of witnessed apnea, and reduction in daytime sleepiness with CPAP therapy. OSA severity as assessed by apnea-hypopnea index did not affect compliance with CPAP therapy. Use of anti-depressants and CPAP induced sleep disturbances were associated with poor compliance with CPAP therapy.

Conclusions

Obesity, excessive daytime sleepiness, witnessed apnea and improvement of daytime symptoms following use of CPAP were predictors of improved compliance. Use of antidepressants and CPAP induced sleep disturbances were predictors of poor compliance.

【 授权许可】

   
2014 Hussain et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T: Type 2 Diabetes, Glycemic Control, and Continuous Positive Airway Pressure in Obstructive Sleep Apnea. Arch Intern Med 2005, 165(4):447-452.
• [2]Hussain SF, Cloonan YK, Islam M, Rahbar MH: Prevalence and associated risk factors of sleep-disordered breathing symptoms in young and middle-aged Pakistani employed adults. Sleep Breath 2010, 14:137-144.
• [3]Howard ME, Desai AV, Grunstein RR, Hukins C, Armstrong JG, Joffe D, Swann P, Campbell DA, Pierce RJ: Sleepiness, sleep-disordered breathing, and accident risk factors in commercial vehicle drivers. Am J Respir Crit Care Med 2004, 170:1014-1021.
• [4]Marin JM, Carrizo SJ, Vicente E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
• [5]Norman D, Loredo JS, Nelesen RA, Ancoli-Israel S, Mills PJ, Ziegler MG, Dimsdale JE: Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006, 47:840-845.
• [6]Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ: Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006, 3:CD001106.
• [7]Sopkova Z, Dorkova Z: Tkacova R Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome. Wien Klin Wochenschr 2009, 121(11–12):398-404.
• [8]Weaver TE, Grunstein RR: Adherence to Continuous Positive Airway Pressure Therapy; The Challenge to Effective Treatment. Proc Am Thorac Soc 2008, 5:173-178.
• [9]Zozula R, Rosen R: Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 2001, 7:391-398.
• [10]Berkani K, Dimet J, Breton P, Bizieux-Thaminy A, Berruchon J: Management of the sleep apnoea syndrome in a general hospital J. Rev Mal Respir. J Rev Mal Respir 2012, 29(7):871-877.
• [11]Johns MW: A new method for measuring daytime sleepiness. The Epworth Sleepiness Scale. Sleep 1991, 14:540-545.
• [12]Collard P, Pieters T, Aubert G, Delguste P, Rodenstein DO: Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev 1997, 1:33-44.
• [13]Wang Y, Gao W, Sun M, Chen B: Adherence to CPAP in patients with obstructive sleep apnea in a Chinese population. Respir Care 2012, 57(2):238-243.
• [14]Hui DS, Ko FW, Chan JK, To KW, Fok JP, Ngai JC, Chan MC, Tung A, Chan DP, Ho CW, Lai CK: Sleep-disordered breathing and continuous positive airway pressure compliance in a group of commercial bus drivers in Hong Kong. Respirology 2006, 11(6):723-730.
• [15]Billings ME, Auckley D, Benca R, Foldvary-Schaefer N, Iber C, Redline S, Rosen CL, Zee P, Kapur VK: Race and residential socioeconomics as predictors of CPAP adherence. Sleep 2011, 34(12):1653-1658.
• [16]Bakker JP, O’Keeffe KM, Neill AM, Campbell AJ: Ethnic disparities in CPAP adherence in New Zealand: effects of socioeconomic status, health literacy and self-efficacy. Sleep 2011, 34(11):1595-1603.
• [17]Zonato AI, Bittencourt LR, Martinho FL, Baiard P, Togeiro SM, Benedito-Silva AA, Tufik S: A comparison of public and private obstructive sleep apnea clinics. Braz J Med Biol Res 2004, 37:69-76.
• [18]Johnson MK, Carter R, Nicol A, Paton R, Banham SW: Long-term continuous positive airway pressure (CPAP) outcomes from a sleep service using limited sleep studies and daycase CPAP titration in the management of obstructive sleep apnoea/hypopnoea syndrome. Chron Respir Dis 2004, 1(2):83-88.
• [19]McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ: Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999, 159:1108-1114.
• [20]Hollandt JH, Mahlerwein M: Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA). Sleep Breath 2003, 7(2):87-94.
• [21]Sin DD, Mayers I, Man GC, Pawluk L: Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002, 121(2):430-435.
• [22]Waldhorn RE, Herrick TW, Nguyen MC, O’Donnell AE, Sodero J, Potolicchio SJ: Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990, 97:33-38.
• [23]Engleman HM, Martin SE, Douglas NJ: Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax 1994, 49:263-266.
• [24]Hui DS, Choy DK, Li TS, Ko FW, Wong KK, Chan JK, Lai CK: Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest 2001, 120:170-176.
• [25]Janson C, Noges E, Svedberg-Randt S, Lindberg E: What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment? Respir Med 2000, 94:145-149.
• [26]Wild MR, Engleman HM, Douglas NJ, Espie CA: Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J 2004, 24:461-465.
• [27]Kjelsberg FN, Ruud EA, Stavem K: Predictors of symptoms of anxiety and depression in obstructive sleep apnea. Sleep Med 2005, 6(4):341-346.
• [28]Lewis KE, Seale L, Bartle IE, Watkins AJ, Ebden P: Early predictors of CPAP use for the treatment of obstructive sleep apnea. Sleep 2004, 27:134-138.
• [29]Hoffstein V, Viner S, Mateika S, Conway J: Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 1992, 145:841-845.